Christopher M. Grochowski

Christopher M. Grochowski

Auto-generated profile, based on publicly available information

Christopher M. Grochowski

Baylor College of Medicine

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Gene
Verified
Journal Article
Closed access
CGChristopher M. Grochowski
Christopher M. Grochowski
KLKathleen M. Loomes
Kathleen M. Loomes
NSNancy B. Spinner
Nancy B. Spinner

9 July 2022 in Trends in Genetics
Verified
Journal Article
Open access
JSJakob Schuy
Jakob Schuy
CGChristopher M. Grochowski
Christopher M. Grochowski
CCClaudia M.B. Carvalho
Claudia M.B. Carvalho
ALAnna Lindstrand
Anna Lindstrand
Complex genomic rearrangements (CGRs) are known contributors to disease but are often missed during routine genetic screening. Identifying CGRs requires (i) identifying copy number variants (CNVs) concurrently with inversions, (ii) phasing multiple breakpoint junctions in cis, as well as (iii) detecting and resolving structural variants (SVs) within repeats. We demonstrate how combining cytogenetics and new sequencing methodologies is being successfully applied to gain insights into the genomic architecture of CGRs. In addition, we review CGR patterns and molecular features revealed by studying constitutional genomic disorders. These data offer invaluable lessons to individuals interested in investigating CGRs, evaluating their clinical relevance and frequency, as well as assessing their impact(s) on rare genetic diseases.

5 April 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MSMoritz Smolka
Moritz Smolka
LPLuis F. Paulin
Luis F. Paulin
CGChristopher M. Grochowski
Christopher M. Grochowski
DHDominic W. Horner
Dominic W. Horner
MMMedhat Mahmoud
Medhat Mahmoud
FSFritz Sedlazeck
Fritz Sedlazeck
Long-read Structural Variation (SV) calling remains a challenging but highly accurate way to identify complex genomic alterations. Here, we present Sniffles2, which is faster and more accurate than state-of-the-art SV caller across different coverages, sequencing technologies, and SV types. Furthermore, Sniffles2 solves the problem of family- to population-level SV calling to produce fully genotyped VCF files by introducing a gVCF file concept. Across 11 probands, we accurately identified causative SVs around MECP2 , including highly complex alleles with three overlapping SVs. Sniffles2 also enables the detection of mosaic SVs in bulk long-read data. As a result, we successfully identified multiple mosaic SVs across a multiple system atrophy patient brain. The identified SV showed a remarkable diversity within the cingulate cortex, impacting both genes involved in neuron function and repetitive elements. In summary, we demonstrate the utility and versatility of Sniffles2 to identify SVs from the mosaic to population levels.

9 October 2013 in Human Genetics
Verified
Journal Article
Closed access
PDF file
ETEllen A. Tsai
Ellen A. Tsai
CGChristopher M. Grochowski
Christopher M. Grochowski
KLKathleen M. Loomes
Kathleen M. Loomes
KBKazuhiko Bessho
Kazuhiko Bessho
HHHakon Hakonarson
Hakon Hakonarson
MDMarcella Devoto
Marcella Devoto

11 March 2015 in Human Mutation
Verified
Journal Article
Closed access
PDF file
ETEllen A. Tsai
Ellen A. Tsai
CGChristopher M. Grochowski
Christopher M. Grochowski
AFAlexandra M. Falsey
Alexandra M. Falsey
RRRamakrishnan Rajagopalan
Ramakrishnan Rajagopalan
DWDanielle Wendel
Danielle Wendel
NSNancy B. Spinner
Nancy B. Spinner

1 September 2016 in Cellular and Molecular Gastroenterology and Hepatology
Verified
Journal Article
Open access
ETEllen A. Tsai
Ellen A. Tsai
MGMelissa A. Gilbert
Melissa A. Gilbert
CGChristopher M. Grochowski
Christopher M. Grochowski
LULara A. Underkoffler
Lara A. Underkoffler
HMHe Meng
He Meng
KLKathleen Loomes
Kathleen Loomes
Alagille syndrome is an autosomal-dominant, multisystem disorder caused primarily by mutations in JAG1, resulting in bile duct paucity, cholestasis, cardiac disease, and other features. Liver disease severity in Alagille syndrome is highly variable, however, factors influencing the hepatic phenotype are unknown. We hypothesized that genetic modifiers may contribute to the variable expressivity of this disorder. We performed a genome-wide association study in a cohort of Caucasian subjects with known pathogenic JAG1 mutations, comparing patients with mild vs severe liver disease, followed by functional characterization of a candidate locus. We identified a locus that reached suggestive genome-level significance upstream of the thrombospondin 2 (THBS2) gene. THBS2 codes for a secreted matricellular protein that regulates cell proliferation, apoptosis, and angiogenesis, and has been shown to affect Notch signaling. By using a reporter mouse line, we detected thrombospondin 2 expression in bile ducts and periportal regions of the mouse liver. Examination of Thbs2-null mouse livers showed increased microvessels in the portal regions of adult mice. We also showed that thrombospondin 2 interacts with NOTCH1 and NOTCH2 and can inhibit JAG1-NOTCH2 interactions. Based on the genome-wide association study results, thrombospondin 2 localization within bile ducts, and demonstration of interactions of thrombospondin 2 with JAG1 and NOTCH2, we propose that changes in thrombospondin 2 expression may further perturb JAG1-NOTCH2 signaling in patients harboring a JAG1 mutation and lead to a more severe liver phenotype. These results implicate THBS2 as a plausible candidate genetic modifier of liver disease severity in Alagille syndrome.